According to a new report from Intel Market Research, the global diabetes drugs market was valued at US$ 88.96 billion in 2025 and is projected to reach US$ 198.73 billion by 2032, growing at a robust CAGR of 12.1% during the forecast period (2025–2032). This exceptional growth trajectory is directly attributed to the escalating global diabetes epidemic, continuous pharmaceutical...